title: Primary care trusts reverse advice to ophthalmologists to use cheaper drug for wet age related macular degeneration.
authors: Nigel
authors: N
authors: Hawkes
mesh_terms: D020533:Angiogenesis Inhibitors / Q000191:economics* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000191:economics* / Q000627:therapeutic use; D000068258:Bevacizumab; D004345:Drug Industry / Q000331:legislation & jurisprudence; D004739:England; D006801:Humans; D056687:Off-Label Use / Q000191:economics* / Q000331:legislation & jurisprudence; D000069579:Ranibizumab; D013222:State Medicine; D057135:Wet Macular Degeneration / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D000069579:Ranibizumab